Keep up to date what’s happening at DASI Simulations. If you’re a member of the news media with an inquiry, please contact info@dasisim.com for a timely response.
DASI Simulations was recently featured in a 10TV news segment highlighting the impact of Accelerating Angels, a Dublin-based organization dedicated to investing in and supporting women-led businesses.
Cleveland Clinic has partnered with the biomedical technology company DASI Simulations, LLC, to further validate the predictive modeling technology for simulating transcatheter aortic replacement procedures.
Medtronic and DASI Simulations partner to advance the future of TAVR through predictive modeling and personalized planning
Medtronic and DASI Simulations partner to advance the future of TAVR through predictive modeling and personalized planning
Cleveland Clinic Collaborates with DASI Simulations to Create AI-Powered Technology for Structural Heart Care
Dublin-based DASI Simulations LLC has signed 35 health systems to software subscriptions, including one of the country’s largest structural heart programs.
DASI Simulations Closes Third Funding Round of $5 Million; Finalizes 11 Commercial Agreements for Its AI-Powered Predictive Modeling Products for Structural Heart Care
The year-old Ohio State Early Investor Network links alumni to companies with a university connection and growth potential.
The year-old Ohio State Early Investor Network links alumni to companies with a university connection and growth potential.
DASI Simulations today announced Drs. Guiherme Attizzani, Hasan A. Jilaihawi, and Martin B. Leon have joined the company’s Medical Advisory Board.
DASI Simulations, a startup founded in 2020 by Georgia Tech professor Dr. Lakshmi Dasi and Teri Sirset, aims to address this issue with predictive artificial intelligence (AI) that enables personalized and optimized treatment.
DASI Simulations, a startup founded in 2020 by Georgia Tech professor Dr. Lakshmi Dasi and Teri Sirset, aims to address this issue with predictive artificial intelligence (AI) that enables personalized and optimized treatment.
Accelerating Angels, an angel investment fund and network giving women-owned startup companies the capital they need to scale their businesses, has selected the recipient of its third investment – DASI SImulations
Accelerating Angels, an angel investment fund and network giving women-owned startup companies the capital they need to scale their businesses, has selected the recipient of its third investment – DASI SImulations
Explore the latest research on the feasibility of valve-in-valve transcatheter aortic valve implantation post-aortic root replacement.
Explore the latest research on the feasibility of valve-in-valve transcatheter aortic valve implantation post-aortic root replacement.
Accelerating Angels, an angel investment fund and network giving women-owned startup companies the capital they need to scale their businesses, has selected the recipient of its third investment – DASI SImulations
Explore the latest research on the feasibility of valve-in-valve transcatheter aortic valve implantation post-aortic root replacement.
DASI Simulations featured in CityScene Magazine for healthcare innovation stemming from Dublin, Ohio.
DASI Simulations featured in CityScene Magazine for healthcare innovation stemming from Dublin, Ohio.
Purpose Jobs, the Midwest’s largest startup and tech community, today announced DASI Simulations to its list of companies with the best culture. The list covered companies around the Midwest, as well as remote companies that are actively hiring in emerging tech hubs.
DASI Simulations, a leading innovator in AI-driven healthcare technologies, proudly announces its inclusion in the esteemed shortlist for the inaugural Global Cardiovascular Awards.
DASI Simulations as CMS grants approval for a $1000 reimbursement per report for PrecisionTAVI, marking a pivotal moment for the FDA-cleared predictive modeling product designed for transcatheter aortic valve replacement (TAVR).
DASI Simulations, a startup founded in 2020 by Georgia Tech professor Dr. Lakshmi Dasi and Teri Sirset, aims to address this issue with predictive artificial intelligence (AI) that enables personalized and optimized treatment.
Purpose Jobs, the Midwest’s largest startup and tech community, today announced DASI Simulations to its list of companies with the best culture. The list covered companies around the Midwest, as well as remote companies that are actively hiring in emerging tech hubs.
On the heels of receiving FDA clearance for its first product – Precision TAVI – DASI Simulations announced today it has been selected as a member of MedTech Innovator’s 2023 Accelerator program. DASI Simulations is the only Ohio-based start-up selected for the 2023 cohort.
AI for Preprocedural TAVR Modeling Gains FDA Clearance Diagnostic & Interventional Cardiology — June 9, 2023 – Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic
DASI Simulations Chosen for MedTech Innovator’s 2023 Accelerator Cohort DASI Simulations is honored to be chosen for MedTech Innovator’s 2023 Accelerator Cohort. MedTech Innovator is the world’s largest accelerator of
DASI Simulation’s Precision TAVI earns FDA Clearance Precision TAVI is the first FDA approved predictive modeling tool for medical teams planning TAVR procedures Cath Lab Digest — Dublin, OH —
US FDA approval for AI TAVI planning software CardiovascularNews — June 8, 2023 – DASI Simulations has announced it has received US Food and Drug Administration (FDA) clearance for its artificial
AI for preprocedural TAVR modeling gains FDA clearance Healio — June 7, 2023 – Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic
‘To the moon’ – Ohio State spinoff gets FDA approval for heart surgery simulation software By Carrie Ghose – Staff reporter for Columbus Business First Columbus, OH — June 6,
Precision TAVI is the first FDA approved predictive modeling tool for medical teams planning TAVR procedures.
Artificial Intelligence Improves Outcomes of Heart Valve Patients DASI Simulations, uses AI and computer vision in its technology for personalized and more accurate heart valve replacement modeling. Péralte C. Paul
Startup aiming for FDA clearance to open ‘floodgates’ on heart surgery simulation software By Carrie Ghose - Staff reporter for Columbus Business First Columbus, OH — January 2023 – An Ohio State
DASI Simulations Named Top Midwest Startups & Tech Companies to Watch in 2023 Columbus, OH — January 10, 2023 – Purpose Jobs, the Midwest’s largest startup and tech community, announced DASI Simulations,
DASI Simulations Named One of Columbus’ Top StartUps Columbus, OH — January – DASI Simulations is so excited to be a part of the tech growth in Columbus and cannot
DASI Named One of Columbus’ top startups and innovators for 2022 DASI Simulations is excited to announce that we have been named one of Columbus’ top startups and innovators. Columbus,
TechOhio: This Ohio Startup Wants to Give Heart Surgeons an Innovative New Resource How DASI Simulations wants to combat heart disease through their revolutionary tech https://youtu.be/CP–1SZ_Zqw Read original story on
DASI Paper on Biomechanics of TAVR Complications and Computational Predictive Modeling Published Transcatheter aortic valve replacement (TAVR) is a rapidly growing field enabling replacement of diseased aortic valves without the
DASI Simulations to Attend and Present at TVT: The Structural Heart Summit 2022 in Chicago Sharing Our Focus on Digital Applications for Personalized Planning and Lifetime TAVR Management DASI Simulations
DASI Featured in Advances in Aortic Valve Surgery webinar During this special webinar, you will learn how medical experts are using DASI Simulations’ 3D imaging technologies, artificial intelligence, and minimally-invasive
DASI Founders Present at American College of Cardiology ACC22 From April 2 – 4, thousands of cardiovascular professionals from around the globe came together to debate and discuss practice-changing science
DASI Simulations Secures $1.5 Million in Seed Round Funding Funds will accelerate AI-driven solution to improve heart surgery outcomes Columbus, OH — February 2022 – Dasi Simulations, LLC, the leading
DASI Simulations Awarded Technology Validation and Start-Up Grant Columbus, Ohio — February 2, 2022 — DASI Simulations has been honored with one of just six grant from The Ohio Third
The new publication “Predictive Model for Thrombus Formation After Transcatheter Valve Replacement” by Dr. Hatoum et al. highlights the value DASI Simulations’s proprietary computational predictive modeling brings towards optimal life-long management considerations for heart valve replacement.
DASI Simulations Named One of Ohio’s Best Health Startups Columbus, Ohio — October 11, 2021 — DASI Simulations has been honored with being named one of BestStartups’ Best Health Diagnostic